Babineaux-Fontenot Claire 4
4 · ABBOTT LABORATORIES · Filed Apr 28, 2026
Research Summary
AI-generated summary of this filing
Abbott (ABT) Director Claire Babineaux-Fontenot Receives Award
What Happened
- Claire Babineaux-Fontenot, a director of Abbott Laboratories (ABT), received a grant of 2,286 restricted stock units (RSUs) on 2026-04-24. The grant was reported on a Form 4 filed 2026-04-28. The grant price/value is shown as $0.00 in the filing (typical for RSU awards when granted rather than sold).
Key Details
- Transaction date: 2026-04-24; Form 4 filed: 2026-04-28.
- Award: 2,286 RSUs; reported acquisition price: $0.00; reported dollar amount: $0.
- Shares owned after transaction: not specified in the provided filing.
- Footnote: RSUs granted under the Abbott Laboratories 2026 Incentive Stock Program. The award will convert one-for-one into Abbott common shares upon the earlier of the director’s separation from service, death, or a change in control.
- No late-filing flag is indicated in the provided information.
Context
- This is a compensation award (A = Award/Grant), not an open-market purchase or sale. RSU grants are routine director compensation and do not by themselves indicate a buy/sell signal. The shares will be issued in the future if and when vesting/payment conditions are met (separation, death, or change in control).
Insider Transaction Report
Form 4
Babineaux-Fontenot Claire
Director
Transactions
- Award
Common shares without par value
[F1]2026-04-24+2,286→ 7,603 total
Footnotes (1)
- [F1]Restricted stock unit award granted under the Abbott Laboratories 2026 Incentive Stock Program (the "Program"). The award will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).
Signature
/s/ Claire Babineaux-Fontenot by Jessica H. Paik, Attorney-in-Fact|2026-04-28